throbber
Page 1
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________________
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________________
` ZIMMER HOLDINGS, INC. and ZIMMER, INC.,
` Petitioner,
` V.
` BONUTTI SKELETAL INNOVATIONS LLC,
` Patent Owner.
`__________________________________________
` Case IPR2014-00191
` Patent 7,837,736
`__________________________________________
` Virtua Health & Wellness Building
` 401 Young Avenue - Suite 245
` Moorestown, New Jersey 08057
` October 11, 2014
` 8:54 A.M.
`
` ORAL DEPOSITION OF
` SCOTT D. SCHOIFET, M.D.
`
`Zimmer EXHIBIT 1022
`Zimmer Holdings, Inc. and Zimmer, Inc. v.
`Bonutti Skeletal Innovations LLC
`REPORTED BY:
`IPR2014-00191
`DEBRA SAPIO LYONS, RDR, CRR, CCR, CPE
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 2
`
` October 11, 2014
`
` Oral deposition of
`Scott D. Schoifet, M.D., held at the
`Virtua Health & Wellness Building, 401
`Young Avenue - Suite 245, Moorestown, New
`Jersey 08057, before Debra Sapio Lyons, a
`Registered Diplomat Reporter, a Certified
`Realtime Reporter, a Certified LiveNote
`Reporter, an Approved Reporter of the
`United States District Court for the
`Eastern District of Pennsylvania, a
`Certified Court Reporter of the State of
`New Jersey, a Notary Public of the States
`of New Jersey, New York and the
`Commonwealth of Pennsylvania.
`
`1234
`
`56
`
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 3
`
`APPEARANCES:
` PAUL HASTINGS LLP
` BY: NAVEEN MODI, ESQUIRE
` PAROMITA CHATTERJEE, ESQUIRE
` 875 15th Street, N.W.
` Washington, D.C. 20005
` 202.551.1990
` naveenmodi@paulhastings.com
` mitachatterjee@paulhastings.com
` Counsel for Petitioner
` DAVIDSON, DAVIDSON & KAPPEL, LLC
` BY: CARY S. KAPPEL, ESQUIRE
` DAVID PETROFF, ESQUIRE
` 485 Seventh Avenue - 14th Floor
` New York, New York 10018
` 212.736.1940
` ckappel@ddkpatent.com
` dpetroff@ddkpatent.com
` Counsel for Patent Owner
`
`1
`2
`3
`4
`5
`6
`
`78
`
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:22) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 4
`
` Scott D. Schoifet, M.D.,
` having been first duly sworn, was
` examined and testified as follows:
` - - -
` COURT REPORTER: Stipulations?
` MR. KAPPEL: No.
` - - -
` E X A M I N A T I O N
` - - -
`BY MR. MODI:
` Q. Good morning, Dr. Schoifet.
` A. Good morning.
` Q. Would you please spell your
`full name for the record?
` A. Sure. It's Scott,
`S-C-O-T-T, Schoifet, S-C-H-O-I-F-E-T.
` Q. And what is your address?
` A. 19 Macclesfield Drive,
`Medford, New Jersey.
` Q. Have you ever testified
`before?
` A. I have.
` Q. So you understand you're
`under oath today --
`
`12
`
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:23) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 5
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. Yes.
` Q. -- like you would be in a
`Court of Law?
` A. Yes.
` Q. And I'm going to ask you
`questions and the answers will be
`transcribed.
` You understand that?
` A. Yes.
` Q. We'll take breaks
`frequently. I just ask if a question
`is pending, that you answer it before
`we take a break.
` Is that fair?
` A. Yes.
` Q. Of course your attorney may
`object, and if he has a privilege
`objection, then, of course, we'll take
`a break if you need to. You understand
`that?
` A. Yes.
` Q. And if he does object, you
`do need to answer unless he instructs
`you not to answer.
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:24) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 6
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` Do you understand that too?
` A. Yes.
` Q. If a question is not clear,
`please let me know and I'll rephrase
`it; otherwise I'm going to assume you
`understand it.
` Is that fair?
` A. Yes.
` Q. We are going to try to only
`have one speaker at a time. I think
`she will definitely appreciate it, so
`do you understand that?
` A. Yes.
` Q. Do you have any questions
`before we begin?
` A. No, I don't.
` Q. Any reason you cannot
`testify completely and accurately
`today?
` A. No, there's not.
` Q. What did you do to prepare
`for this deposition today?
` A. I reviewed the -- the
`documents, the patent, '736, the patent
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:25) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 7
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`history, the declaration by your
`expert, the -- I forget the name.
`The -- the case, the patent review that
`was done. I can't give you the exact
`terms without my declaration.
` Q. IPR, Inter --
` A. Yeah, the IPR review.
` Q. Anything else?
` A. To the best of my knowledge
`without re-looking at my declaration,
`that would be most of it.
` Q. So you obviously looked at
`your declaration?
` A. Yes, of course.
` Q. What about Walker?
` A. I reviewed Walker of course.
`It's hard for me to do this from memory
`sometimes.
` Q. I totally understand.
` And how long did you spend
`to prepare for your deposition?
` A. I spent quite a number of
`hours on it.
` Q. How many hours
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:26) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 8
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`approximately?
` A. Many. It's hard for me to
`judge. Go back to records at home. I
`spent a long time reviewing the
`documents, looking at Walker, reading
`the dec -- reading the other
`declaration, reviewing the cases and
`the patent's quite extensive, so quite
`a long period of time.
` Q. And over what period did you
`prepare for the deposition?
` A. It was -- for the
`deposition, probably months. For the
`declaration, probably a month or two.
` Q. Did you talk to anyone to
`prepare for your deposition?
` MR. KAPPEL: Objection. I'm
` just going to caution the witness
` that you are not to disclose the
` substance of any communication with
` counsel.
` THE WITNESS: I had
` discussions with my attorneys.
`BY MR. MODI:
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:27) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 9
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` Q. Which attorneys?
` A. The two present here.
` Q. Anyone else?
` A. About the case, no.
` Q. What is your general
`understanding of the subject matter
`that's at issue here?
` A. Subject matter is whether or
`not Walker anticipates the claims of
`the patent's Claims 21, 22 and 31.
` Q. And the patent that we're
`talking about is the '736 Patent; is
`that right?
` MR. KAPPEL: Objection,
` form.
` THE WITNESS: The patent
` that I reviewed -- well, I'm trying
` to remember. There's a lot of
` patents I reviewed, so I want to
` make sure we're talking about the
` right number. If you have the
` patent for me to look at, I can
` confirm it's the one I reviewed.
` I'd rather not do it by memory and
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:28) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 10
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` give you a erroneous answer.
`BY MR. MODI:
` Q. This proceeding involves
`Bonutti and Zimmer; right?
` MR. KAPPEL: Objection,
` form.
` THE WITNESS: It involves
` the Walker patent and Claims 21, 22
` and 31.
`BY MR. MODI:
` Q. Do you have any
`understanding as to the parties that
`are involved in these proceedings?
` A. I'm not sure what you mean
`by "understanding."
` Q. Well, were you retained by
`someone for this IPR proceeding?
` A. I was retained by Bonutti
`Skeletal.
` Q. And you understand that this
`proceeding involves a patent owned by
`Bonutti Skeletal?
` A. I do.
` Q. What is the general subject
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:19) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 11
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`matter of the patent -- of that patent?
` A. The patent is quite
`extensive and there's multiple subjects
`in it and multiple claims.
` Q. You mentioned Claims 21, 22
`and 31; right?
` A. I did.
` Q. What do those claims relate
`to?
` A. I can't recall from memory.
`If you want me to give you an accurate
`answer, I'd have to be reading it.
` Q. Have you had any design
`experience with any products?
` A. I have had design experience
`with Stryker.
` Q. So these are Stryker
`products?
` A. I've had design experience
`with Stryker products.
` Q. Any other products?
` A. No, not outside of Stryker.
` Q. And what was your first
`design -- design experience with
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:20) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 12
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`Stryker?
` A. It was Scorpio. For their
`minimally invasive Scorpio anterior
`referencing equipment, they had a set
`of instruments. That's my initial
`design experience.
` Q. And what time frame was
`that?
` A. That would have been around
`2003 or 2004.
` Q. And you referred to that as
`the Scorpio. Can you give us the name
`again?
` A. It was the anterior --
`minimally invasive surgical, MIS for
`short, anterior referencing
`instruments.
` Q. Can you generally describe
`those instruments?
` A. It would be difficult to
`generally describe them. There's a
`manual for those instruments you can
`look at.
` Q. What are they used for?
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:21) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 13
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. They're using for performing
`a knee replacement.
` Q. Besides the Scorpio product,
`were you involved in any other products
`with Stryker?
` A. I helped design the anterior
`referencing instrumentation for the
`Triathlon Knee System and have been
`involved with the design of the
`Tritanium, T-R-I-T-A-N-I-U-M, knee
`replacements for tibial base plate for
`the Triathlon Knee System.
` Q. Going back to the Scorpio
`MIS product, what were your
`contributions in that design?
` A. For that product I designed
`the protective plate that was used for
`the patella specifically.
` Q. Was anyone else involved in
`the design?
` A. With the design, I need a
`clarification of that. Was anybody
`else with the design of the entire
`Scorpio system or of that product, the
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:22) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 14
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`plate?
` Q. Let's start with the plate.
` A. No.
` Q. So that was just you?
` A. Uh-huh.
` Q. What if you made it broader,
`the product?
` A. I would have no answer to
`that. I don't know who was involved
`with it.
` Q. Have you ever worked with
`Dr. Bonutti?
` A. I've worked with him, yes.
` Q. In what capacity?
` A. We've been at meetings
`together. He's a consultant with
`Stryker. And we consider those
`meetings work where we're teaching
`other -- other surgeons.
` Q. Was Dr. Bonutti involved in
`the Scorpio MIS project?
` A. I assume so, but I can't
`give you a definitive answer. I wasn't
`involved in the beginning of that
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:23) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 15
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`project.
` Q. But why do you assume that
`he was involved?
` A. He was using the instruments
`at the time that I was learning how to
`use the instruments as well.
` Q. Was he involved in the
`design of those instruments?
` MR. KAPPEL: Objection,
` form.
` THE WITNESS: I don't have
` direct knowledge of that. That's an
` assumption I made he was.
`BY MR. MODI:
` Q. And what's the basis of that
`assumption?
` A. That he was -- that he was
`using the instruments.
` Q. Going to the Triathlon
`products that you mentioned, I think
`there are two of them that you
`mentioned; right?
` A. Yes.
` Q. Let's start with the
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:24) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 16
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`Triathlon anterior references --
`referencing MIS instrument. I hope I
`got that right.
` A. You did.
` Q. When did you work on that
`product?
` A. I'll be guessing on the time
`frame, but I think it was in 2006 to
`2007 range.
` Q. And what were your
`contributions there?
` A. They were manyfold. I was
`much more involved in the
`instrumentations. I would get early
`designs and comment on them and help
`spec with them changes, so it's too
`numerous for me to recount.
` MR. KAPPEL: I'm just going
` to make an objection and just a
` caution to the witness. I know
` we're now discussing your work with
` Stryker who is not a party to this
` proceeding and I don't know whether
` or not there are any confidentiality
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:25) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 17
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` issues you may have with Stryker,
` but if you do, then you need to
` consider that when answering
` questions.
`BY MR. MODI:
` Q. Did anyone else -- let me
`withdraw that.
` Was anyone else involved in
`the Triathlon anterior referencing MIS
`instrument project?
` A. I wouldn't be privy to that.
` Q. What about Dr. Bonutti?
` A. I wasn't privy to who was in
`it. That would include Dr. Bonutti.
` Q. And then going to the last
`product you mentioned which I believe
`was the Triathlon tibial plate.
` A. The Tritanium.
` Q. Sorry. Right. The
`Tritanium tibial plate.
` A. Uh-huh.
` Q. When did you -- when were
`you involved in that project?
` A. That's ongoing.
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:26) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 18
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` Q. When did it start?
` A. Probably three years ago.
` Q. And I'm not looking for any
`confidential information, so can you
`just generally describe what that
`product is?
` A. It's an uncemented base
`plate designed not to be used with
`cement; and the metal is a titanium.
`It's called Tritanium. It's porous
`metal.
` Q. Other than the products that
`we just discussed, have you had any
`design experience with any other
`products?
` A. Mostly designing the
`Tritanium patella which is part of that
`system, so that would include
`everything I've designed.
` Q. And aside from your work
`with Stryker, have you had any other
`design experience?
` A. Not to my recollection.
` Q. You indicated you've
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:27) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 19
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`testified before; right?
` A. Correct.
` Q. How many times?
` A. Once to my knowledge.
` Q. And what proceeding was that
`for?
` A. It was another prior art.
` Q. Another inter partes review
`proceeding?
` A. Uh-huh.
` Q. Did it involve a patent
`owned by Bonutti?
` A. It did.
` Q. So you indicated you were
`retained by Bonutti Skeletal in this
`proceeding; right?
` A. Correct.
` Q. How did you -- how were you
`approached?
` MR. KAPPEL: I'm going to
` lodge an objection, caution the
` witness not to reveal the substance
` of any communication of counsel.
` THE WITNESS: My secretary
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20)(cid:28) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 20
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` received a phone call from the
` attorneys office Stroock & Stroock.
`BY MR. MODI:
` Q. So it was through Stroock &
`Stroock that you got involved in these
`pro -- in this proceeding?
` A. Initially. There was also a
`phone call from Dr. Bonutti as well.
` Q. And what was the phone call
`from Dr. Bonutti about?
` A. Both phone calls were asking
`to speak with me.
` Q. Okay. And then what did you
`discuss with Dr. Bonutti?
` A. Well, I discussed with
`Stroock & Stroock first about the --
`that there was a case, he was
`interested to see if I'd be interested
`in participating as an expert.
` Q. Okay. And then you said
`there was a discussion --
` A. I had --
` Q. -- following discussion with
`Dr. Bonutti?
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:19) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 21
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. I had a discussion with
`Dr. Bonutti, asked me if I would be
`willing to give my time to be an expert
`in this case.
` Q. And was -- what else was
`discussed during that discussion with
`Dr. Bonutti?
` A. That was the discussion.
` Q. And I assume you said yes?
` A. I did.
` Q. Would you say you are
`friends with Dr. Bonutti?
` A. No.
` Q. What would -- how would you
`characterize your relationship with
`Dr. Bonutti?
` A. We characterize orthopedists
`we work with as colleagues. That's the
`term I would use.
` Q. How many times have you
`worked together with Dr. Bonutti?
` A. At meetings and such, it's
`somewhere between three and five.
` Q. Have you worked with him in
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:20) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 22
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`any other connection?
` A. I did. When I initially
`wanted to learn how to do a minimally
`invasive technique, I asked my Stryker
`rep to -- who's -- who's doing it, and
`Dr. Bonutti was doing these
`quad-sparing techniques, so I flew out
`to Effingham to observe him do surgery.
` Q. In the meetings where you
`worked with Dr. Bonutti, what's your
`work been there?
` A. Usually we're instructors
`for Stryker, so a lot of them are
`surgical techniques. There are
`breakout sessions where we might
`discuss other topics as well.
` Q. And who are these -- who are
`you teaching at these meetings?
` A. Other surgeons.
` Q. Other than the initial
`discussion that you had with
`Dr. Bonutti, have you had any other
`discussion with him regarding the
`cases?
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:21) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 23
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. I have not.
` Q. So you haven't spoken to
`Dr. Bonutti about this proceeding after
`that initial discussion?
` A. I have not.
` Q. And you haven't talked to
`him about your testimony?
` A. I have not.
` Q. Are you being compensated
`for your time?
` A. I am.
` Q. What is your hourly rate?
` A. $1,250.00.
` Q. And who is compensating you?
` A. It's with Bonutti Skeletal
`Innovations.
` Q. Besides the IPR proceedings
`that you mentioned, have you done any
`other consulting work with Bonutti?
` A. No.
` Q. Have you been involved in
`any litigations?
` A. In our practice, an
`orthopedics litigation could be many,
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:22) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 24
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`many things.
` Q. That's fair. Let me -- let
`me make that -- have you been involved
`in any litigations involving the
`Bonutti patents?
` A. Just the prior IPR that I
`mentioned. Let me amend that. I'm
`also involved with Desmarais for
`other -- against other companies. I
`think there's suits against Smith
`and -- Smith & Nephew and Biomet.
` Q. And these involve Bonutti
`patents?
` A. They involve Bonutti
`patents.
` Q. And what's your role in
`those cases?
` A. I'm -- my role is as an
`expert.
` Q. And have you given any
`testimony in those cases?
` A. I have not given testimony.
` Q. Have you submitted any
`expert reports?
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:23) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 25
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. I have submitted an expert
`report.
` Q. What's -- what's the general
`subject matter?
` A. It was a -- it's a DePuy
`case.
` Q. And what did your report
`relate to?
` A. I have too many things. I
`can't recall exactly what the report
`related to without it in front of me.
`I could give you erroneous information.
` Q. So other than the DePuy
`case -- and I think you mentioned
`Biomet?
` A. I believe it was Biomet.
` Q. Other than the DePuy, Biomet
`and these IPR proceedings, have you
`done any other consulting work for
`Bonutti?
` A. I can't recall any others.
` Q. You mentioned Desmarais.
`How do you know Mr. Desmarais?
` A. I do not know Mr. Desmarais.
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:24) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 26
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` Q. Okay. But you -- you said
`you've done work with Mr. Desmarais?
` A. I didn't say I did work with
`Mr. Desmarais.
` Q. So -- but I think his name
`was mentioned.
` A. That's the attorney. That's
`the firm.
` Q. Oh, got it. Okay. Okay.
` So are you working with
`anyone at that firm in particular?
` A. I'm working with an attorney
`with Desmarais, correct.
` Q. And what's his name?
` A. Alex Henriques.
` Q. Do you know when were you
`first retained by Bonutti for any of
`the legal proceedings?
` A. Could you repeat that?
` Q. Sure. You know, you've
`mentioned you've been involved in a
`bunch of legal proceedings with
`Bonutti, right, as an expert?
` A. Uh-huh.
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:25) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 27
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` Q. What was the first time?
` A. The DePuy case I think was
`the first.
` Q. And --
` A. The --
` Q. Sorry. Go ahead.
` A. I'm sorry. It was with the
`Stroock & Stroock firm. And I believe
`there was a change of firms along the
`way.
` Q. Okay. Any rec --
`recollection as to the time frame?
` A. I'd be guessing somewhat,
`but I think it was about a year, in the
`last -- probably within the last year I
`started consulting work.
` Q. And you've been paid for all
`your consulting work for Bonutti;
`right?
` A. I have submitted invoices
`for all the consulting work.
` Q. And you've been paid for at
`least some of those invoices?
` A. Correct.
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:26) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 28
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` Q. How much do you think you've
`been paid over the -- since you were
`first retained by Bonutti?
` A. I believe it's $10,000.00.
` Q. And how much is outstanding?
` A. I can't recall.
` Q. Is it more than 10,000?
` A. I would believe so.
` Q. More than 20?
` A. I can't answer that.
` Q. Have you ever done any legal
`consulting work for anyone other than
`Bonutti?
` A. Not that I can recall.
` Q. Do you have any patents?
` A. I do not.
` Q. Other than the Bonutti cases
`that we've been discussing, do you have
`any experience with patents?
` A. Once when I was a resident I
`was looking to patent a type of cement.
`I was talking to a patent attorney.
`Never went anywhere.
` Q. Why didn't it go anywhere?
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:27) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 29
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. There was already prior art.
` Q. What is your understanding
`of prior art?
` A. My understanding, especially
`from that, was that somebody else had
`already come up with something
`extremely similar to what you're trying
`to patent.
` Q. And you didn't try to patent
`anything after that?
` A. No, I gave up.
` Q. So other than this one
`experience for -- of trying to get a
`patent and the Bonutti cases, have you
`had any other experience with patents?
` A. No.
` MR. MODI: I'm going to hand
` you what's been marked previously as
` Exhibit 1002.
` (Exhibit 1002, United States
` Patent Number 5,755,801, was
` previously marked for
` identification.)
` THE WITNESS: Okay.
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21)(cid:28) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 30
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`BY MR. MODI:
` Q. Can you please identify
`Exhibit 1002 for us?
` A. It's Patent Number 5,755,801
`by Walker.
` Q. And this is the Walker
`patent we were referring to earlier
`today?
` A. I believe so.
` Q. Can I have you turn to sheet
`two -- or that has the Figures 2, 2a
`2b, 2c in Exhibit 1002? Let me know
`when you're there.
` A. I'm there.
` Q. These figures show an Item
`50 and an Item 51.
` Do you see those?
` A. I do.
` Q. And Item 50 is referred to
`as an abutment?
` MR. KAPPEL: Objection,
` foundation.
`BY MR. MODI:
` Q. Is that right?
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:22)(cid:19) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 31
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
` A. A semi-circular abutment,
`50.
` Q. So Item 50 is referred to as
`an abutment?
` MR. KAPPEL: Objection,
` form.
` THE WITNESS: To the best of
` my knowledge, it says it's a
` semi-circular abutment.
`BY MR. MODI:
` Q. And where are you reading
`this from?
` A. Column 4, Line 24, 23 and
`24.
` Q. Would you agree Item 50 is
`upstanding or upright?
` A. I can't tell from the
`two-dimensional picture.
` Q. And the two-dimensional
`picture you're referring to?
` A. 2a.
` Q. So what would you need to
`have to -- for you to say whether it's
`an upstanding -- it -- it's up --
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:22)(cid:20) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 32
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`upstanding or upright?
` MR. KAPPEL: Objection,
` foundation.
` THE WITNESS: I would not
` know what I'd need to have. I can
` comment on what's in front of me.
`BY MR. MODI:
` Q. Okay. So based on the
`figure, it's your testimony that
`abutment 50 is -- you cannot tell that
`it's upstanding or upright; is that
`right?
` A. Based on Figure 2a of the
`patent, you cannot tell whether it's
`upstanding or upright.
` Q. Do any of the other figures
`help you?
` A. No.
` Q. Anything else in the
`disclosure that helps you?
` A. I'm not sure what you mean
`by anything else in the disclosure.
` Q. In the document.
` A. In this document? Referring
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:22)(cid:21) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 33
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` SCOTT D. SCHOIFET, M.D.
`to what's in the patent, it calls
`Figure 50 a semi-circular abutment, so
`I assume it meant -- I assume that
`Figure 50, it says here, it's
`controlled by a semi-circular abutment,
`50 -- not Figure 50 -- 50 which is in
`Figure 2a.
` Q. My question is: Does any --
`in the patent, looking at this patent,
`can you tell us whether abutment 50 is
`upstanding or upright?
` MR. KAPPEL: Objection,
` form.
` THE WITNESS: It says very
` clearly to me in that sentence that
` it's a -- in Figure 2a, 50 is a
` semi-circular abutment.
` MR. MODI: Can you read back
` my question, please?
` (The following portion of
` the record is read by the Court
` Reporter:
` "QUESTION: My question is:
` Does anything in the patent, looking
`
`212-279-9424
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:22)(cid:22) (cid:82)(cid:73) (cid:20)(cid:25)(cid:24)
`
`VERITEXT REPORTING COMPANY
`www.veritext.com
`
`212-490-3430
`
`

`

`Page 34
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket